The severe acute respiratory syndrome coronavirus (SARS-CoV) synthesizes several
putative viral envelope proteins, including the spike (S), membrane (M), and small envelope …

Severe acute respiratory syndrome-associated coronavirus (SARS-CoV) is a rapidly
emerging pathogen with potentially serious consequences for public health. Here we …

Public health measures successfully contained outbreaks of the severe acute respiratory
syndrome coronavirus (SARS-CoV) infection. However, the precursor of the SARS-CoV …

The production of virus-like particles (VLPs) constitutes a relevant and safe model to study
molecular determinants of virion egress. The minimal requirement for the assembly of VLPs …

The SARS-coronavirus (SARS-CoV) is the etiological agent of severe acute respiratory
syndrome (SARS). The SARS-CoV spike (S) glycoprotein mediates membrane fusion events …

To promote viral entry, replication, release, and spread to neighboring cells, many cytolytic
animal viruses encode proteins responsible for modification of host cell membrane …

The severe acute respiratory syndrome-associated coronavirus (SARS-CoV) causes severe
pneumonia with a fatal outcome in approximately 10% of patients. SARS-CoV is not closely …

The spike protein (S) of severe acute respiratory syndrome coronavirus (SARS-CoV) is
responsible for receptor binding and membrane fusion. It contains a highly conserved …

Enveloped viruses have evolved membrane glycoproteins (GPs) that mediate entry into host
cells. These proteins are important targets for antiviral therapies and vaccines. Several …

Post-translational modifications and correct subcellular localization of viral structural
proteins are prerequisites for assembly and budding of enveloped viruses. Coronaviruses …